• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥洛罗芬对多种菌种具有活性,包括对氟康唑活性降低的分离菌株。

Olorofim demonstrates activity against species, including isolates against which fluconazole has reduced activity.

作者信息

Wiederhold Nathan P, Patterson Hoja P, Ferrer Dora, Garcia Victor, Thompson George R, Patterson Thomas F

机构信息

Fungus Testing Laboratory, Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

Division of Infectious Diseases, Department of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

出版信息

Antimicrob Agents Chemother. 2025 Jan 31;69(1):e0098824. doi: 10.1128/aac.00988-24. Epub 2024 Nov 21.

DOI:10.1128/aac.00988-24
PMID:39570032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11784075/
Abstract

We evaluated the activity of olorofim against species. Olorofim demonstrated potent activity against all isolates tested with a minimum inhibitory concentration (MIC) range ≤0.008-0.06 µg/mL and geometric mean MIC of 0.010 µg/mL. This activity was also maintained against isolates with elevated fluconazole MICs (≥16 µg/mL), including strains with MICs ≥32 µg/mL (olorofim MIC range ≤0.008-0.06 µg/mL and geometric mean MICs of ≤0.009 and ≤0.013 µg/mL, respectively).

摘要

我们评估了奥洛罗芬对多种菌种的活性。奥洛罗芬对所有测试分离株均表现出强效活性,最低抑菌浓度(MIC)范围≤0.008 - 0.06 µg/mL,几何平均MIC为0.010 µg/mL。对于氟康唑MIC升高(≥16 µg/mL)的分离株,包括MIC≥32 µg/mL的菌株,这种活性也得以维持(奥洛罗芬MIC范围分别为≤0.008 - 0.06 µg/mL,几何平均MIC分别≤0.009和≤0.013 µg/mL)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f775/11784075/69465acb1c51/aac.00988-24.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f775/11784075/69465acb1c51/aac.00988-24.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f775/11784075/69465acb1c51/aac.00988-24.f001.jpg

相似文献

1
Olorofim demonstrates activity against species, including isolates against which fluconazole has reduced activity.奥洛罗芬对多种菌种具有活性,包括对氟康唑活性降低的分离菌株。
Antimicrob Agents Chemother. 2025 Jan 31;69(1):e0098824. doi: 10.1128/aac.00988-24. Epub 2024 Nov 21.
2
The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis.奥罗托米德奥洛洛芬在中枢神经系统球孢子菌病的实验模型中有效。
Antimicrob Agents Chemother. 2018 Aug 27;62(9). doi: 10.1128/AAC.00999-18. Print 2018 Sep.
3
Antifungal susceptibility profiles of Coccidioides immitis and Coccidioides posadasii from endemic and non-endemic areas.来自流行区和非流行区的粗球孢子菌和波萨达斯球孢子菌的抗真菌药敏谱。
Mycopathologia. 2007 Jun;163(6):315-9. doi: 10.1007/s11046-007-9018-7. Epub 2007 May 7.
4
In vitro and in vivo activities of posaconazole against Coccidioides immitis.泊沙康唑对粗球孢子菌的体外及体内活性
Antimicrob Agents Chemother. 2002 May;46(5):1352-6. doi: 10.1128/AAC.46.5.1352-1356.2002.
5
EUCAST olorofim MICs for 3,550 Danish mold and dermatophyte isolates from 2020 to 2023.2020年至2023年从丹麦分离出的3550株霉菌和皮肤癣菌的欧盟CAST奥利罗芬最低抑菌浓度。
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0035325. doi: 10.1128/aac.00353-25. Epub 2025 Jun 26.
6
enhances iron uptake to maintain fluconazole resistance.增强铁摄取以维持氟康唑耐药性。
Infect Immun. 2025 Mar 11;93(3):e0000225. doi: 10.1128/iai.00002-25. Epub 2025 Feb 7.
7
In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from Northeast, Brazil.卡泊芬净、两性霉素B和唑类药物对来自巴西东北部的波萨达斯球孢子菌菌株的体外活性。
Mycopathologia. 2006 Jan;161(1):21-6. doi: 10.1007/s11046-005-0177-0.
8
Synergistic antifungal effect of thiophene derivative as an inhibitor of fluconazole-resistant Candida spp. biofilms.噻吩衍生物作为氟康唑耐药念珠菌生物膜抑制剂的协同抗真菌作用。
Braz J Microbiol. 2024 Dec;55(4):3667-3677. doi: 10.1007/s42770-024-01470-3. Epub 2024 Aug 7.
9
Large-Scale Evaluation of Amphotericin B, Triazole, and Echinocandin Activity against Coccidioides Species from U.S. Institutions.对来自美国机构的球孢子菌属物种进行的两性霉素B、三唑类和棘白菌素活性的大规模评估。
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02634-16. Print 2017 Apr.
10
Antifungal Potential of Streptomyces-Derived Metabolites Against Fluconazole-Resistant Oral Candida albicans: In vitro Evaluation and Mechanistic Insights.链霉菌来源的代谢产物对氟康唑耐药的口腔白色念珠菌的抗真菌潜力:体外评估及机制探究
Iran Biomed J. 2025 May 1;29(3):9-19. doi: 10.61186/ibj.4937.

引用本文的文献

1
Coccidioidomycosis: a growing global concern.球孢子菌病:日益引起全球关注。
J Antimicrob Chemother. 2025 Mar 14;80(Supplement_1):i40-i49. doi: 10.1093/jac/dkaf002.

本文引用的文献

1
Infectious Diseases in a Changing Climate.气候变化中的传染病
JAMA. 2024 Apr 16;331(15):1318-1319. doi: 10.1001/jama.2023.27724.
2
In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents.新型抗真菌药物奥洛罗芬对丝状真菌的体外活性及与其他八种抗真菌药物的比较
J Fungi (Basel). 2021 May 12;7(5):378. doi: 10.3390/jof7050378.
3
Expansion of Coccidioidomycosis Endemic Regions in the United States in Response to Climate Change.美国球孢子菌病流行区域因气候变化而扩大。
Geohealth. 2019 Oct 10;3(10):308-327. doi: 10.1029/2019GH000209. eCollection 2019 Oct.
4
Re-drawing the Maps for Endemic Mycoses.重新绘制地方病真菌图谱。
Mycopathologia. 2020 Oct;185(5):843-865. doi: 10.1007/s11046-020-00431-2. Epub 2020 Feb 10.
5
The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis.奥罗托米德奥洛洛芬在中枢神经系统球孢子菌病的实验模型中有效。
Antimicrob Agents Chemother. 2018 Aug 27;62(9). doi: 10.1128/AAC.00999-18. Print 2018 Sep.
6
The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis.新型真菌 Cyp51 抑制剂 VT-1598 对新型隐球菌(posadasii)和荚膜组织胞浆菌(immitis)引起的中枢神经系统球孢子菌病的实验模型有效。
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02258-17. Print 2018 Apr.
7
In vitro activity of the novel antifungal compound F901318 against Australian Scedosporium and Lomentospora fungi.新型抗真菌化合物F901318对澳大利亚瓶霉属和卷枝霉属真菌的体外活性
Med Mycol. 2018 Nov 1;56(8):1050-1054. doi: 10.1093/mmy/myx161.
8
In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.新型抗真菌化合物 F901318 对难治疗的曲霉属分离株的体外活性。
J Antimicrob Chemother. 2017 Sep 1;72(9):2548-2552. doi: 10.1093/jac/dkx177.
9
Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.二氢乳清酸脱氢酶抑制剂 F901318 对枝顶孢属和 prolificans 属具有很强的体外活性。
J Antimicrob Chemother. 2017 Jul 1;72(7):1977-1980. doi: 10.1093/jac/dkx065.
10
Large-Scale Evaluation of Amphotericin B, Triazole, and Echinocandin Activity against Coccidioides Species from U.S. Institutions.对来自美国机构的球孢子菌属物种进行的两性霉素B、三唑类和棘白菌素活性的大规模评估。
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02634-16. Print 2017 Apr.